Diagnostic News and Research

RSS

T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke, heart attack victims

T2 Biosystems, a company developing direct detection products enabling superior diagnostics, announced that scientists from the University of Pennsylvania and T2 Biosystems have published a paper in Blood describing novel clot structure biology detected while testing T2 Bio's T2HemoStat-.

10 Jan 2014

Bipolar screening tools not tailored to young people

Current screening tools for bipolar disorder are poorly validated in the age group most at risk for developing the condition, say researchers.

9 Jan 2014

Zyomyx's MyT4 point-of-care CD4 diagnostic test receives CE mark approval

Mylan, Inc. today announced that Zyomyx's MyT4 point-of-care CD4 diagnostic test has received the CE Certificate of Conformity in the European Union, an important step toward launching this innovative test and expanding access to affordable, accessible and reliable diagnostics for people living with HIV globally.

9 Jan 2014

Illumina signs multi-year licensing agreement with Quest Diagnostics

Illumina, Inc. today announced it has entered into a multi-year licensing agreement with Quest Diagnostics, the world's leading provider of diagnostic information services, related to the use of Illumina's next-generation sequencing technology for clinical laboratory testing.

From Illumina, Inc. 9 Jan 2014

Researchers develop new, safer and noninvasive diagnostic technique for ulcers

Doctors may soon be able to diagnose stomach ulcers without taking tissue samples from the stomach. Researchers from the University of Southern Denmark now report to have developed a new, safer and noninvasive diagnostic technique for ulcers.

8 Jan 2014

Long follow-up needed after acute or transient psychotic disorder diagnosis

The validity of the International Classification of Diseases-10 category of acute and transient psychotic disorders is debatable, say researchers who found that around half of patients moved to a different category within a few years.

8 Jan 2014

C. parvum and cryptosporidiosis: an interview with Dr. Momar Ndao, McGill University

Cryptosporidium parvum is one of the most common enteropathogens to affect humans in the world. The protozoan parasite causes a gut infection referred to as cryptosporidiosis.

8 Jan 2014

Carl Zeiss Meditec acquires 100% of shares in Aaren Scientific

Carl Zeiss Meditec AG announces it has acquired, through its subsidiary Carl Zeiss Meditec Inc., 100% of the shares in Aaren Scientific Inc., a US-based manufacturer of intraocular lenses (IOLs). Aaren Scientific, headquartered in Ontario, California, has been manufacturing IOLs for more than two decades. The majority of shares in Aaren Scientific had previously been owned by a private investment company as well as other investors, including the CEO and co-founder of Aaren Scientific, Rick Aguilera, who along with the entire management team will stay on board after the transaction.

8 Jan 2014

OASIS receives research award from MJFF to develop saliva-based, rapid test for Parkinson's detection, diagnosis

Oasis Diagnostics Corporation is the recipient of a research award from The Michael J. Fox Foundation for Parkinson's Research to validate OASIS' development of a non-invasive, saliva-based, rapid test for Parkinson's disease detection and diagnosis.

8 Jan 2014

Sanford Health gifts $125M to establish Imagenetics program that integrates genomic medicine into primary care for adults

Sanford Health announced today Denny Sanford, the preeminent health care philanthropist in the United States, will gift the organization $125 million to establish Sanford Imagenetics, a first-of-its-kind program in the country that integrates genomic medicine into primary care for adults.

8 Jan 2014

Insight Genetics receives $1.5M SBIR contract to research on resistance mutations in NSCLC patients

Insight Genetics, Inc. today announced it has received a new $1.5 million Phase II Small Business Innovation Research contract from the National Cancer Institute.

8 Jan 2014

Research highlights potential of newly developed radiopharmaceuticals for imaging melanoma metastases

With low survival rates for patients with metastasized melanoma, accurate staging and effective treatments are critical to extending life. New research published in the Journal of Nuclear Medicine highlights the potential of newly developed radiopharmaceuticals with benzamide for the imaging of metastases and as a targeted systemic therapy.

8 Jan 2014

Applied BioCode signs License and Supply Agreement with Genetic Analysis for BMB technology

Applied BioCode announced today that it has signed a License and Supply Agreement for its Barcoded Magnetic Bead technology with Genetic Analysis of Oslo, Norway.

7 Jan 2014

ICD-10-CM training sessions for health care professionals

Affiliated Medical Billing, an affiliate of Yeo & Yeo CPAs & Business Consultants, will host ICD-10-CM training sessions at locations throughout Michigan beginning in January 2014.

7 Jan 2014

A&D Medical releases secure, flexible platform to help people manage their health

For everyone from patients to quantified selfers, A&D Medical today announced the release of its next generation Wellness Connected®, a secure, flexible platform to help people increase physical activity and manage their health.

7 Jan 2014

Navidea Biopharmaceuticals, GMST sign distribution agreement for Lymphoseek Injection in Taiwan

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today it has entered into a distribution agreement for Lymphoseek (technetium Tc 99m tilmanocept) Injection in Taiwan with Global Medical Solutions Taiwan, Ltd., a leading in-country distributor of nuclear medicine and diagnostic imaging products.

7 Jan 2014

Memorial Sloan-Kettering Cancer Center receives $90M in new financial support from Ludwig

Memorial Sloan-Kettering Cancer Center, along with five other elite academic institutions, will share an unprecedented total of $540 million in new financial support from Ludwig Cancer Research, on behalf of its founder Daniel K. Ludwig. Announced today, the gift is among the largest publicly recorded gifts to cancer research made by a private organization, bringing the total funding to date for Ludwig Centers and endowed professorships at the six institutions to $900 million.

7 Jan 2014

Study shows binge-eating disorder is associated with substantial lifelong impairments

Binge-eating disorder, designated in 2013 by the American Psychiatric Association as a diagnosis in its Diagnostic and Statistical Manual of Mental Disorders-V, is associated with substantial lifelong impairments comparable to those of bulimia nervosa, according to a recent World Health Organization study based on community epidemiological surveys conducted in 12 nations worldwide.

7 Jan 2014

Sleep duration predicts chronic depression and anxiety

Short and long sleep duration, but not insomnia, predict a chronic course of depressive and anxiety disorders independent of symptom severity, research indicates.

6 Jan 2014

People with severe mental illness may have higher risk for substance use

People with severe mental illness such as schizophrenia or bipolar disorder have a higher risk for substance use, especially cigarette smoking, and protective factors usually associated with lower rates of substance use do not exist in severe mental illness, according to a new study funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

5 Jan 2014

Diagnostic News and Research

T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke, heart attack victims

Bipolar screening tools not tailored to young people

Zyomyx's MyT4 point-of-care CD4 diagnostic test receives CE mark approval

Illumina signs multi-year licensing agreement with Quest Diagnostics

Researchers develop new, safer and noninvasive diagnostic technique for ulcers

Long follow-up needed after acute or transient psychotic disorder diagnosis

C. parvum and cryptosporidiosis: an interview with Dr. Momar Ndao, McGill University

Carl Zeiss Meditec acquires 100% of shares in Aaren Scientific

OASIS receives research award from MJFF to develop saliva-based, rapid test for Parkinson's detection, diagnosis

Sanford Health gifts $125M to establish Imagenetics program that integrates genomic medicine into primary care for adults

Insight Genetics receives $1.5M SBIR contract to research on resistance mutations in NSCLC patients

Research highlights potential of newly developed radiopharmaceuticals for imaging melanoma metastases

Applied BioCode signs License and Supply Agreement with Genetic Analysis for BMB technology

ICD-10-CM training sessions for health care professionals

A&D Medical releases secure, flexible platform to help people manage their health

Navidea Biopharmaceuticals, GMST sign distribution agreement for Lymphoseek Injection in Taiwan

Memorial Sloan-Kettering Cancer Center receives $90M in new financial support from Ludwig

Study shows binge-eating disorder is associated with substantial lifelong impairments

Sleep duration predicts chronic depression and anxiety

People with severe mental illness may have higher risk for substance use

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News